Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria
Sign Up to like & getrecommendations! Published in 2020 at "Nature Communications"
DOI: 10.1038/s41467-020-16731-6
Abstract: The emergence of antimicrobial-resistant bacteria is an increasingly serious threat to global health, necessitating the development of innovative antimicrobials. Here we report the development of a series of CRISPR-Cas13a-based antibacterial nucleocapsids, termed CapsidCas13a(s), capable of… read more here.
Keywords: crispr cas13a; cas13a based; development; target ... See more keywords